Evidence map›Paper›PMID 40375202›Full record

ArticleBMC psychiatry2025

Relationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study.

Cong Cao, Xuehao Xu, Sumei Shen, Xiyan Bao, Fenglan Wang, Weishan Sun, Tao Gu, Lingling Hua, Chengbing Huang, Zhenlin Chen and 2 more

Abstract readMulticenter Study
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cong CaoDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Xuehao XuDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Sumei ShenDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Xiyan BaoDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Fenglan WangDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Weishan SunDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Tao GuDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China.
Lingling HuaDepartment of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, China.
Chengbing HuangDepartment of Psychiatry, Huai'an No.3 People's Hospital, Huaian, 223001, People's Republic of China.
Zhenlin ChenDepartment of Psychiatry, Taizhou No.5 People's Hospital, Taizhou, 225300, People's Republic of China.
Xuebin QuSchool of Basic Medical Sciences, Jiangsu Medical College, Yancheng, 224005, China. xuebinqu@jsmc.edu.cn.
Aihua ZhouDepartment of Psychiatry, The Fourth People's Hospital of Yancheng, Yancheng, 224003, China. zhouaihuaycsy@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveClinically stable inpatients with schizophrenia have generalized impairment of cognitive function along with abnormalities in renal function, but the link between cognitive function and renal function has been underexplored.

methodsThis study enrolled 216 hospitalized patients with clinically stable schizophrenia. Demographic and renal function parameters were collected from electronic medical records. Cognitive function was assessed using the Chinese Brief Cognitive Test (C-BCT). To analyze the correlations between renal function and processing speed, attention, working memory, and executive function in patients hospitalized with clinically stable schizophrenia. Covariate-adjusted linear and multivariate logistic regression models were constructed to determine the relationship between renal function and cognitive function. ROC analysis was used to further investigate the prediction of renal function indices in assessing stable schizophrenia inpatients.

resultsSignificant variations in serum Cystatin C (CysC), β2-microglobulin (β2-MG), and uric acid (UA) levels were observed among hospitalized patients with clinically stable schizophrenia across different cognitive impairment severities. Correlation analysis revealed a significant association between serum CysC levels and C-BCT scores in hospitalized patients with stable schizophrenia (β = 0.174, 95%CI:0.265 ~ 1.720, p = 0.008). Particularly strong correlations were observed with processing speed T-scores (β = -0.200, 95%CI: -33.446 ~ -7.230, p = 0.03) and executive function T-scores (β = -0.171, 95%CI: -17.277 ~ -2.082, p = 0.013). Binary logistic regression analysis further confirmed that CysC may be a risk factor for exacerbation of cognitive impairment in stable schizophrenia (OR = 12.741, 95%CI: 1.424 ~ 114.005, p = 0.023). The combined serum CysC, β2-MG, and UA test for cognitive function in stable schizophrenia inpatients had an AUC area of 0.71, with a sensitivity and specificity of 79.5% and 60.5%, respectively, and a predictive value superior to that of an independent diagnosis.

conclusionIn hospitalized patients with stable schizophrenia, serum CysC levels are positively correlated with the severity of cognitive impairment, particularly showing significant associations with information processing speed and executive function. CysC may be a risk factor for exacerbating cognitive impairment in these patients. The combined diagnostic value of serum CysC, β2-MG, and UA demonstrated moderate accuracy in identifying stable schizophrenia cognitive impairment. These data support the potential of CysC as a biomarker of cognitive function in stable schizophrenia.

Indexed as

Cognitive DysfunctionSchizophreniaAdultbeta 2-MicroglobulinCross-Sectional StudiesCystatin CExecutive FunctionFemaleHumansMaleMiddle AgedNeuropsychological TestsUric Acidbeta 2-MicroglobulinCystatin CUric AcidC-BCTCognitive impairmentCystatin Cβ2-microglobulinStable schizophreniaUric acid

Identifiers

PMID40375202
PMCPMC12082902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.